Abstract:Background: Diabetic nephropathy (DN) is one of the major diabetic microvascular complications, and macrophage polarization plays a key role in the development of DN. Endothelial cells regulate macrophage polarization. Peroxisome proliferator-activated receptor (PPAR)-α agonists were demonstrated to prevent DN and improve endothelial function. In this study, we aimed to investigate whether PPAR-α agonists prevented DN through regulating macrophage phenotype via improving endothelial cell function. Methods: Eight-week-old male C57BLKS/J db/m and db/db mice were given fenofibrate or 1% sodium carboxyl methylcellulose by gavage for 12 weeks. Results: Db/db mice presented higher urinary albumin-to-creatinine ratio (UACR) than db/m mice, and fenofibrate decreased UACR in db/db mice. Fibrosis and collagen I were elevated in db/db mouse kidneys compared with db/m mouse kidneys; however, they were decreased after fenofibrate treatment in db/db mouse kidneys. Apoptosis and cleaved caspase-3 were enhanced in db/db mouse kidneys compared to db/m mouse kidneys, while fenofibrate decreased them in db/db mouse kidneys. Db/db mice had a suppression of p-endothelial nitric oxide synthase (eNOS)/t-eNOS and nitric oxide (NO), and an increase of angiopoietin-2 and reactive oxygen species (ROS) in kidneys compared with db/m mice, and fenofibrate increased p-eNOS/t-eNOS and NO, and decreased angiopoietin-2 and ROS in db/db mouse kidneys. Hypoxia-inducible factor (HIF)-1α and Notch1 were promoted in db/db mouse kidneys compared with db/m mouse kidneys, and were reduced after fenofibrate treatment in db/db mouse kidneys. Furthermore, the immunofluorescence staining indicated that M1 macrophage recruitment was enhanced in db/db mouse kidneys compared to db/m mouse kidneys, and this was accompanied by a significant increase of tumor necrosis factor (TNF)-α and interleukin (IL)-1β in kidneys and in serum of db/db mice compared with db/m mice. However, fenofibrate inhibited the renal M1 macrophage recruitment and cytokines associated with M1 macrophages in db/db mice. Conclusions: Our study indicated that M1 macrophage recruitment due to the upregulated HIF-1α/Notch1 pathway induced by endothelial cell dysfunction involved in type 2 diabetic mouse renal injury, and PPAR-α agonist fenofibrate prevented DN by reducing M1 macrophage recruitment via inhibiting HIF-1α/Notch1 pathway regulated by endothelial cell function in type 2 diabetic mouse kidneys.

Effect of fenofibrate on the expression of miR-26a-5p/PTEN in retinal neurons of diabetic mice

Fenofibrate Exerts Protective Effects In Diabetic Retinopathy Via Inhibition Of The Angptl3 Pathway

Fenofibrate ameliorates diabetic retinopathy by modulating Nrf2 signaling and NLRP3 inflammasome activation

Fenofibrate Improves Vascular Endothelial Function and Contractility in Diabetic Mice

Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress–mediated Wnt/β-catenin pathway activation

Effect of Fenofibrate on Adiponectin Gene Expression and Endothelial Function in Diabetic Rats

Mechanisms for the therapeutic effect of fenofibrate on diabetic retinopathy and its clinical application

Effect Of Pyridone Agent On Blood-Retinal Barrier In Diabetic Mice

PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway

PPAR-α Agonist Fenofibrate Prevented Diabetic Nephropathy by Inhibiting M1 Macrophages via Improving Endothelial Cell Function in db/db Mice

Fenofibrate Ameliorates Retinal Pigment Epithelium Injury Induced by Excessive Fat Through Upregulation of PI3K/AKT Signaling

Protective effects of total flavonoids from Flos Puerariae on retinal neuronal damage in diabetic mice.

Fenofibrate Ameliorated Systemic and Retinal Inflammation and Modulated Gut Microbiota in High-Fat Diet-Induced Mice

Fenoﬁbrate suppresses cellular metabolic memory of high glucose in diabetic retinopathy via a sirtuin 1-dependent signalling pathway

MicroRNA-183 Repression Ameliorates Mitochondrial Dysregulation and Retinal Degeneration in Mice via P38-MAPK/NF-κB Signaling: Implications for Diabetic Retinopathy

Protective effects of NF-E2-related factor 2 on retinal cells and blood vessels in diabetic mice

Progress in clinical research on the beneficial effects of fenofibrate in diabetic retinopathy

The Protective Effect of Fenofibrate on Acute Focal Cerebral Ischemia Reperfusion Injury in Mice

Study on the Effect and Mechanism of Pirfenidone on Endothelial-Mesenchymal Transition in Endothelial Cells

MiR-19a Inhibitor Improves Diabetic Retinopathy in Rats Through PTEN/Akt/P-Akt Signaling Pathway.

Improvement of inflammatory responses associated with NF-κB pathway in kidneys from diabetic rats